Expertini Research Research

Browse Research Papers

24,281+ open-access research outputs.

✕ Clear
🔍 program development 📄 Peer-Reviewed
Showing 24281 results for "program development" · Peer-Reviewed
Medicine & Health Peer-Reviewed PDF DOI

Building Health Services in a Rapidly Changing Landscape: Lessons in Adaptive Leadership and Pivots in a COVID-19 Remote Monitoring Program.

Celia Violet Laur, Payal Agarwal, Geetha Mukerji, Elaine Goulbourne, Hayley Baranek, Laura Pus, R Sacha Bhatia, Danielle Martin, Onil Bhattacharyya · 2021

Adaptive leadership has become an essential skill for leaders in health systems to respond to the COVID-19 pandemic as new knowledge emerges and case counts rise, fall, and rise again. This leadership…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization.

Drew Weissman, Mohamad-Gabriel Alameh, Thushan de Silva, Paul Collini, Hailey Hornsby, Rebecca Brown, Celia C LaBranche, Robert J Edwards, Laura Sutherland, Sampa Santra, Katayoun Mansouri, Sophie Gobeil, Charlene McDanal, Norbert Pardi, Nick Hengartner, Paulo J C Lin, Ying Tam, Pamela A Shaw, Mark G Lewis, Carsten Boesler, Ugur Sahin, Priyamvada Acharya, Barton F Haynes, Bette Korber, David C Montefiori · 2021

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein acquired a D614G mutation early in the pandemic that confers greater infectivity and is now the globally dominant form. T…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.

Olha Holubovska, Denisa Bojkova, Stefano Elli, Marco Bechtel, David Boltz, Miguel Muzzio, Xinjian Peng, Frederico Sala, Cesare Cosentino, Alla Mironenko, Jens Milde, Yuriy Lebed, Holger Stammer, Andrew Goy, Marco Guerrini, Lutz Mueller, Jindrich Cinatl, Victor Margitich, Aartjan J W Te Velthuis · 2021

Pandemic SARS-CoV-2 causes a mild to severe respiratory disease called Coronavirus Disease 2019 (COVID-19). Control of SARS-CoV-2 spread will depend on vaccine-induced or naturally acquired protective…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Who Is Listening? Spokesperson Effect on Communicating Social and Physical Distancing Measures During the COVID-19 Pandemic.

Ahmad Abu-Akel, Andreas Spitz, Robert West · 2021

Effective communication during a pandemic, such as the current COVID-19 crisis, can save lives. At the present time, social and physical distancing measures are the lead strategy in combating the spre…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.

Fatemeh Mirzaei, Seyyed Alireza Vafaei, Ebrahim Abbasi-Oshaghi · 2021
Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Diagnostic Performance of a Blood Urea Nitrogen to Creatinine Ratio-based Nomogram for Predicting In-hospital Mortality in COVID-19 Patients.

Qingquan Liu, Yiru Wang, Xuecheng Zhao, Lixuan Wang, Feng Liu, Tao Wang, Dawei Ye, Yongman Lv · 2021

The novel coronavirus disease (COVID-19) is leading to high morbidity and mortality. This aim of this study was to test whether blood urea nitrogen-to-creatinine ratio (BCR) is a predictor for mortali…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Avoiding the Virtual Pitfall: Identifying and Mitigating Biases in Graduate Medical Education Videoconference Interviews.

Jyothi Marbin, Y-Vonne Hutchinson, Sarah Schaeffer · 2021

Public health concerns related to the COVID-19 pandemic are leading many residency and fellowship programs to transition from in-person to videoconference interviews (VCIs). The magnitude and speed of…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.

Alexandra Pum, Maria Ennemoser, Tiziana Adage, Andreas J Kungl · 2021

The recently identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, the cause of coronavirus disease (COVID-19) and the associated ongoing pandemic, frequently leads to severe …

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.

Cyrielle Fougeroux, Louise Goksoyr, Manja Idorn, Vladislav Soroka, Sebenzile K Myeni, Robert Dagil, Christoph M Janitzek, Max Sogaard, Kara-Lee Aves, Emma W Horsted, Sayit Mahmut Erdogan, Tobias Gustavsson, Jerzy Dorosz, Stine Clemmensen, Laurits Fredsgaard, Susan Thrane, Elena E Vidal-Calvo, Paul Khalife, Thomas M Hulen, Swati Choudhary, Michael Theisen, Susheel K Singh, Asier Garcia-Senosiain, Linda Van Oosten, Gorben Pijlman, Bettina Hierzberger, Tanja Domeyer, Blanka W Nalewajek, Anette Strobaek, Magdalena Skrzypczak, Laura F Andersson, Soren Buus, Anette Stryhn Buus, Jan Pravsgaard Christensen, Tim J Dalebout, Kasper Iversen, Lene H Harritshoj, Benjamin Mordmuller, Henrik Ullum, Line S Reinert, Willem Adriaan de Jongh, Marjolein Kikkert, Soren R Paludan, Thor G Theander, Morten A Nielsen, Ali Salanti, Adam F Sander · 2021

The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of the SARS-CoV-2 spike …

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Allergic reactions to COVID-19 -vaccinations - unveiling the secret(s).

O Pfaar, V Mahler · 2021

Since the beginning of the current pandemic our journal has published a series of important mechanistic and clinical reports of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infect…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis Metabolic Reprograming of Glutamine in Host Cells.

Shiv Bharadwaj, Mahendra Singh, Nikhil Kirtipal, Sang Gu Kang · 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as coronavirus disease 2019 (COVID-19) pandemic, has killed more than a million people worldwide, and researchers are constantly…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Transforming student engagement in COVID-19 remote instruction: a research perspective.

Dave Edyburn · 2021

This paper was developed in response to the article titled, "A design framework for enhancing engagement in student-centered learning: Own it, learn it, share it," by Eunbae Lee and Michael J. Hannafi…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region.

Angelo Musico, Roberto Frigerio, Alessandro Mussida, Luisa Barzon, Alessandro Sinigaglia, Silvia Riccetti, Federico Gobbi, Chiara Piubelli, Greta Bergamaschi, Marcella Chiari, Alessandro Gori, Marina Cretich · 2021

A workflow for rapid SARS-CoV-2 epitope discovery on peptide microarrays is herein reported. The process started with a proteome-wide screening of immunoreactivity based on the use of a high-density m…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Architectured Therapeutic and Diagnostic Nanoplatforms for Combating SARS-CoV-2: Role of Inorganic, Organic, and Radioactive Materials.

Abhijeet Pandey, Ajinkya N Nikam, Sadhana P Mutalik, Gasper Fernandes, Ajjappla Basavaraj Shreya, Bharath Singh Padya, Ruchira Raychaudhuri, Sanjay Kulkarni, Ruth Prassl, Suresh Subramanian, Aruna Korde, Srinivas Mutalik · 2021

Although extensive research is being done to combat SARS-CoV-2, we are yet far away from a robust conclusion or strategy. With an increased amount of vaccine research, nanotechnology has found its way…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

A Mindfulness-Based Intervention for Student Depression, Anxiety, and Stress: Randomized Controlled Trial.

Paul Ritvo, Farah Ahmad, Christo El Morr, Meysam Pirbaglou, Rahim Moineddin · 2021

University students are experiencing higher levels of distress and mental health disorders than before. In addressing mental health needs, web-based interventions have shown increasing promise in over…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19.

Samuel K Lai, Morgan D McSweeney, Raymond J Pickles · 2021

COVID-19, the disease caused by infection with SARS-CoV-2, requires urgent development of therapeutic interventions. Due to their safety, specificity, and potential for rapid advancement into the clin…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

[Progress in research of specific antibody dynamic characteristics in patients with COVID-19].

H T Zhao, Z B Peng, X K Yang, Z L Li, M R Ren, Y Qin, X J Sun, J X Yu, Z J An, N Y Mao, W W Xu, Z J Li · 2021

COVID-19 is an emerging infectious disease caused by SARS-CoV-2. After the infection of the virus, the host immune system is stimulated to produce multifarious specific antibodies to decrease or elimi…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Development and validation of a laboratory risk score for the early prediction of COVID-19 severity and in-hospital mortality.

Salam Bennouar, Abdelghani Bachir Cherif, Amel Kessira, Djamel-Eddine Bennouar, Samia Abdi · 2021

Coronavirus Disease 2019 is characterized by a spectrum of clinical severity. This study aimed to develop a laboratory score system to identify high-risk individuals, to validate this score in a separ…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Comprehensive Meta-Analysis of COVID-19 Global Metabolomics Datasets.

Zhiqiang Pang, Guangyan Zhou, Jasmine Chong, Jianguo Xia · 2021

The novel coronavirus SARS-CoV-2 has spread across the world since 2019, causing a global pandemic. The pathogenesis of the viral infection and the associated clinical presentations depend primarily o…

Read Paper →
Medicine & Health Peer-Reviewed PDF DOI

Randomized controlled trials for alcohol use disorder during the COVID-19 pandemic.

Zoe E Brown, Samantha M Portis, Carline L Fleig, Talia Vasaturo-Kolodner, Robert M Swift, Carolina L Haass-Koffler · 2021

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) altered the logistics of ongoing randomized controlled trials (RCTs). The need to reduce in-person research and clinical activiti…

Read Paper →
← Prev Page 16 of 1215 Next →